Anonymousabout 21 hours ago
The U.S. Supreme Court on May 4, 2026, issued an administrative stay temporarily restoring mail access to the abortion drug mifepristone after the Fifth Circuit blocked telehealth dispensing nationwide. The order, signed by Justice Samuel Alito, keeps the status quo until at least May 11 while the Court considers emergency applications from drugmakers Danco Laboratories and GenBioPro — setting the stage for what could become the most consequential abortion access ruling since Dobbs v. Jackson Women's Health Organization.